High medical malpractice premiums in New York can be linked directly to the state’s large malpractice litigation awards, according to a new study by the Manhattan Institute’s Center for Legal Policy.
Based on a statistical analysis of malpractice premiums and lawsuit awards throughout the nation, the study debunks the argument that high malpractice costs are a result of cyclical insurance-industry trends and price gouging. The findings provide added evidence for the need of malpractice-lawsuit reforms, such as a proposed $250,000 cap on non-economic damages that has been introduced in both houses of the Legislature (A.5674/S.3035, S.4191).
“For the price-gouging hypothesis to make sense, insurance industries must be exercising monopoly power,” the study says. “We find that states with more concentrated insurance industries actually have lower premiums.”
A copy of the full study can be found here:
About the Author
You may also like
The Attorney General’s MFCU SNAFU
Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office.
On T Read More
Healthcare Revelations in the Enacted Budget Financial Plan
The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before.
Read More
Federal Suit Traces Medicaid Fraud to the Top of NYS Government
The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor.
A Read More
Healthcare Highlights in the New State Budget
Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget.
The deal finalized May 27 Read More
Lawmakers Consider Hiking Fees for Filling Prescriptions
UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More
Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax
As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations.
Read More
Albany Wavers on Shutting Down a Medicaid Racket
As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed.
A Read More
Getting to the Bottom of the 340B Drug Discount Boondoggle
Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More